Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
5.12
+0.28 (5.79%)
At close: Aug 28, 2025, 4:00 PM
5.12
0.00 (0.00%)
After-hours: Aug 28, 2025, 4:11 PM EDT
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $650.15 million as of August 28, 2025. Its market cap has increased by 102.66% in one year.
Market Cap
650.15M
Enterprise Value
617.89M
1-Year Change
102.66%
Ranking
Category
Stock Price
$5.12
Market Cap Chart
Since January 5, 2017, Organogenesis Holdings's market cap has increased from $376.60M to $650.15M, an increase of 72.64%. That is a compound annual growth rate of 6.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 614.00M | 44.74% |
| Dec 31, 2024 | 424.20M | -21.44% |
| Dec 29, 2023 | 540.00M | 53.32% |
| Dec 30, 2022 | 352.20M | -70.37% |
| Dec 31, 2021 | 1.19B | 46.45% |
| Dec 31, 2020 | 811.60M | 78.10% |
| Dec 31, 2019 | 455.70M | 30.13% |
| Dec 31, 2018 | 350.20M | -8.90% |
| Dec 29, 2017 | 384.40M | 2.07% |
| Jan 5, 2017 | 376.60M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.76B |
| Johnson & Johnson | 425.05B |
| AbbVie | 368.08B |
| UnitedHealth Group | 272.09B |
| AstraZeneca | 248.21B |
| Novartis AG | 243.97B |
| Novo Nordisk | 243.46B |
| Abbott Laboratories | 229.03B |